0001562180-23-000409.txt : 20230113
0001562180-23-000409.hdr.sgml : 20230113
20230113161932
ACCESSION NUMBER: 0001562180-23-000409
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230111
FILED AS OF DATE: 20230113
DATE AS OF CHANGE: 20230113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Obenshain Andrew
CENTRAL INDEX KEY: 0001839697
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35966
FILM NUMBER: 23528998
MAIL ADDRESS:
STREET 1: C/O BLUEBIRD BIO, INC.
STREET 2: 455 GRAND UNION BOULEVARD
CITY: SOMERVILLE
STATE: MA
ZIP: 02145
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: bluebird bio, Inc.
CENTRAL INDEX KEY: 0001293971
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 455 GRAND UNION BOULEVARD
CITY: SOMERVILLE
STATE: MA
ZIP: 02145
BUSINESS PHONE: 339-499-9300
MAIL ADDRESS:
STREET 1: 455 GRAND UNION BOULEVARD
CITY: SOMERVILLE
STATE: MA
ZIP: 02145
FORMER COMPANY:
FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc
DATE OF NAME CHANGE: 20040616
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2023-01-11
false
0001293971
bluebird bio, Inc.
BLUE
0001839697
Obenshain Andrew
C/O BLUEBIRD BIO, INC.
455 GRAND UNION BOULEVARD
SOMERVILLE
MA
02145
true
true
false
false
President and CEO
Common Stock
2023-01-11
4
S
false
3178.00
7.8043
D
242690.00
D
Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
The range in prices for the transaction reported on this line was $7.61 to $7.93. The average weighted price was $7.8043. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Andrew Obenshain
2023-01-13